Superworth

SI-BONE SIBN

Medical - Instruments & Supplies, Healthcare
$20.22
−4.76%
Market cap
$906.2M
PE
n/m
a loss over the last year
Forward PE
n/m
not a meaningful number
Price to sales
4.2×
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
$213.6M
+15% on a year ago
Net margin
−6.9%
Free cash flow yield
−0.5%

SI-BONE trades at 4.2× sales. Its trailing earnings are negative, so it has no PE. Revenue was $213.6M over the last twelve months, up 15% on a year earlier with a −7% net margin.

Charts

Financials

Income statement for SIBN, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$34M+29%$38.9M+22%$37.9M+16%$40M+20%$40.3M+19%$49M+26%$47.3M+25%$48.6M+22%$48.7M+21%$56.3M+15%$52.6M+11%$56M+15%
Cost of revenue$7M+69%$10.2M+100%$8M+35%$8.4M+33%$8.4M+20%$10.2M+0%$9.6M+20%$9.8M+17%$9.8M+16%$11.8M+16%$10.6M+11%$11.5M+17%
Gross profit$27M+21%$28.7M+7%$29.9M+12%$31.6M+17%$31.9M+18%$38.8M+35%$37.7M+26%$38.8M+23%$38.8M+22%$44.5M+15%$41.9M+11%$44.5M+15%
R&D$3.9M+27%$4.2M+20%$4.3M+32%$4.4M+19%$4M+2%$3.9M−7%$4.5M+4%$4.3M−1%$4.2M+6%$4.4M+13%$4.2M−8%$5.2M+21%
SG&A$34.2M+5%$37M+7%$37.6M+8%$37.3M+6%$35.5M+4%$40.4M+9%$40.6M+8%$41.5M+11%$40M+13%$42.6M+6%$42.8M+5%$44.1M+6%
−$11.2M−18%−$12.5M+11%−$12M+7%−$10.1M−16%−$7.6M−32%−$5.5M−56%−$7.5M−38%−$7M−31%−$5.4M−30%−$2.5M−55%−$5.1M−32%−$4.8M−31%
Interest expense$884K+17%$889K+1%$881K+5%$880K+4%$884K+0%$793K−11%$662K−25%$666K−24%$670K−24%$630K−21%$592K−11%$598K−10%
Net income−$10M−29%−$11M−2%−$10.9M−2%−$8.9M−20%−$6.6M−34%−$4.5M−59%−$6.5M−40%−$6.2M−31%−$4.6M−31%−$1.6M−63%−$4.3M−34%−$4.1M−34%
−$0.25−39%−$0.27−16%−$0.27−16%−$0.22−27%−$0.16−36%−$0.11−59%−$0.15−44%−$0.14−36%−$0.11−31%−$0.04−64%−$0.10−33%−$0.09−36%
40.3M+17%40.6M+17%40.9M+17%41.3M+9%41.7M+4%41.9M+3%42.3M+3%42.8M+4%43.2M+4%43.5M+4%44M+4%44.5M+4%

EPS, diluted: 9 periods, Q4 FY17 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 9 periods, Q4 FY17 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest SI-BONE's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
SIBNSI-BONE$906.2Mn/mn/a4.2×+15%−6.9%
IRMDIradimed$1B42.5×41.5×11.4×+11%26.8%
IARTIntegra Lifesciences$1.1B80.1×46.3×0.6×+1%0.8%
BVSBioventus$1.1B17.1×27.1×1.9×+4%9.4%
MOVMovado$710.9M17.7×13.4×1.0×+5%6.0%
STAAStaar Surgical$1.3B356×144×3.7×+51%1.1%
CDRECadre$1.3B38.9×35.9×2.0×+20%5.3%
EYENational Vision$1.4B28.1×52.7×0.7×+8%2.5%
TCMDTactile Systems Technology$518.1M21.2×62.3×1.5×+17%7.1%
LMATLemaitre Vascular$1.9B28.5×42.0×7.1×+12%25.0%
INSPInspire Medical Systems$1.9B14.5×56.6×2.2×−0%15.0%
Peer median$1.2B28.3×44.1×1.9×+9%6.5%

More on SI-BONE

Each number over time

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .